In This Story
New data shows that government-funded health insurance plans in the United States provide the majority of coverage for popular weight-loss drugs like Novo Nordisks (NVO-1.39%
) Wegovy… [+3235 chars]
Financial Insurance
Government-funded insurance plans are more likely to cover weight-loss drugs than private plans
New data shows that government-funded health insurance plans in the United States provide the majority of coverage for popular weight-loss drugs like Novo Nordisk’s (NVO) Wegovy and Eli Lilly’s (LLY) Zepbound.Read more...
